Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cumberland Pharmaceu (CPIX)

3.48   0.39 (12.62%) 01-26 00:20
Open: 3.1 Pre. Close: 3.09
High: 3.73 Low: 3.08
Volume: 187,762 Market Cap: 51M
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.735 - 3.756 3.756 - 3.775
Low: 3.033 - 3.056 3.056 - 3.078
Close: 3.443 - 3.48 3.48 - 3.514

Technical analysis

as of: 2022-01-25 4:23:05 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.45     One year: 6.60
Support: Support1: 3.08    Support2: 2.56
Resistance: Resistance1: 4.67    Resistance2: 5.65
Pivot: 3.96
Moving Average: MA(5): 3.46     MA(20): 4.16
MA(100): 3.38     MA(250): 3.19
MACD: MACD(12,26): -0.24     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 5.77     %D(3): 3.17
RSI: RSI(14): 41.04
52-week: High: 7.51  Low: 2.20  Change(%): 9.8
Average Vol(K): 3-Month: 5318  10-Days: 172

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CPIX has closed above bottom band by 22.7%. Bollinger Bands are 31.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 03 Jan 2022
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Sees Significant Growth in Short Interest - MarketBeat

Wed, 01 Dec 2021
Cumberland Pharma shares double on FDA approval | Area Stocks | - Nashville Post

Tue, 30 Nov 2021
Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Sh - Benzinga

Tue, 16 Nov 2021
Cumberland Pharmaceuticals to move headquarters to Broadwest development - Nashville Business Journal - Nashville Business Journal

Tue, 09 Nov 2021
Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update - PRNewswire

Tue, 02 Nov 2021
Cumberland Pharmaceuticals To Announce Third Quarter 2021 Financial Results - Hendersonville Standard

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 15
Shares Float (M) 8
% Held by Insiders 44.21
% Held by Institutions 18.94
Shares Short (K) 601
Shares Short P. Month (K) 3

Stock Financials

EPS -0.044
EPS Est This Year 0.090
EPS Est Next Year 0.090
Book Value (p.s.) 3.150
Profit Margin -1.43
Operating Margin -13.37
Return on Assets (ttm) -3.5
Return on Equity (ttm) -6.3
Qtrly Rev. Growth -12.7
Gross Profit (p.s.) 1.952
Sales Per Share 2.572
EBITDA (p.s.) -0.021
Qtrly Earnings Growth
Operating Cash Flow (M) 5
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -79.09
PEG Ratio
Price to Book value 1.10
Price to Sales 1.35
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.